$3.93
At close: Mar 31, 5:45 PM EDT
$3.29
-0.64-16.28%
Pre-Market: Mar 31, 5:45 PM EDT
Comments
Loading...
Eupraxia Pharmaceuticals Earnings Estimates, EPS & Revenue | NASDAQ:EPRX | Benzinga
Eupraxia Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Mar 20
EPS
$-0.220
Quarterly Revenue
$0.00
Annual Revenue
(as of Dec 31)
(as of Dec 31)
–
Analyze the earnings history of Eupraxia Pharmaceuticals using advanced sorting and filters.
Eupraxia Pharmaceuticals (EPRX) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
Eupraxia Pharmaceuticals (EPRX) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is Eupraxia Pharmaceuticals (NASDAQ:EPRX) reporting earnings?
Eupraxia Pharmaceuticals (EPRX) is scheduled to report earnings on May 12, 2025. The last reported earnings were for reported on March 20, 2025 for Q4.
What were the latest earnings per share (EPS) for Eupraxia Pharmaceuticals (NASDAQ:EPRX)?
The Actual EPS was $-0.22, which missed the estimate of $0.00.
What were Eupraxia Pharmaceuticals’s (NASDAQ:EPRX) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.
